Major Seller Exhaustion its got divergences all over the place on every time scale, its at the bottom of a range for 2020. three rising valley bla bla bla. just look at the chart.
PFE trade ideas
Has some turnaround potentialIf 35.20 can hold, I reckon this could test 38 to reset the indicators and start the ramp for ER. Countertrend theory, so test of 38 is key. Otherwise, path of least resistance is down.
PFE Monthly 2021-01-23PFE could have formed a gigantic cup&handle over the course of 21 years.
This can be a solid place to buy PFE for a long term hold.
Also, really not sure if we can apply TA to a timeframe this large, but it's fun to think about.
PFE - EW analysis - ABC cycle down PFE - It is forming flat like B wave, where c of B wave up is in progress. Sell when B wave finished near 39 level for C wave down as expected earlier.
Give thumbs up if you really like the trade idea.
Wait Until The Price Comes Out From The Green BoxPay attention to the Head & Shoulders Patten, if the chart breaks the neck line and then the important support it may decrease until to the head & shoulders target.
Long position for Pfizer Inc?1. Price already at the low of the channel
2. Also aligns with 200DMA
3. BIDEN PROMISED 100 MILLION VACCINATIONS WITHIN 100 DAYS OF OFFICE, other countries will be looking vaccinate too that implies production and thats value for the company
BUY $PFE - NRPicks Ene 17Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. Pfizer mainly sells prescription drugs and vaccines, also spends a leading amount on research and development, close to $8 billion annually.
The company has developed its COVID-19 vaccine, however, it has not reflected its optimism in the stock price. The company has generated the same income quarter by quarter during the year, so we can see a good future for the development of its vaccine and the development of the new strain of the virus.
Fundamentals:
- Value
- P/B 3.1x VS 4.3x Industry
- ROE 22% vs. 17% industry
Technicians:
- Price level below SMA 250-200-150
- Williams R% at -50% levels
- RSI (40) Midlevel
- +1% average upside during the month
As a result of the allergic reactions to the vaccine presented, PFE presented a 15% correction from December 8 to December 31, which stopped at a support of $36.3. From this point on, the stock presented a change in trend, which could continue due to the fact that the stock is below its medium term moving average.
Pfizer INCPfizer and BioNTech made a vaccine from coronavirus and when it will come out for everyone, the price will grow up. It’s nice position for buy⬆️
Pfizer Inc. Ready to Launch The Rocket 🚀🚀🚀💡 Trade Idea
📈 Buy Limit Pfizer Inc. @ 36.70
🎯 Target Profit 43.08
🛑 Stop Loss 34.80
❌ Do not risk more than 1 % of your account on each trade
🙂 Good Luck !
Description:
The price was ranging inside a parallel channel near a confluence zone between the daily support and the 61.8% Fibonacci retracement. We have a low volume, but our expectation that it will increase, and this will lead to a breakout of the channel to the upside, and then a huge move to the 43.08 mark.
-------------------------------------------------------------------------------------
Please press “Like” if you appreciate the trading idea 👍
“Follow” for more trading ideas in the future 👀
“Comment” below to share your thoughts with us and other traders 👥
-------------------------------------------------------------------------------------
Risk Disclaimer: All trading ideas published by collegeofpips are for educational purposes only. These posts can help you to enhance your trading skills, but please do your own research before opening any trading position. ⚠️
Pfizer long confirmedIn addition to the portfolio long on Pfizer will be added as the session starts. Double doji candles and MACD crossover and RSI is rising above 50 are enough as confirmation. I've been tracking PFE since the end of December and now an opportunity to buy stocks of the company has revealed. My target is $44 - $44.80.
PFIZER - 1D - SUPERSTOCK 21 - BREAKOUTExceeding range high. Bottom of upward channel. Bullish divergence on 1d chart, MACD. Weekly stochastic 5 oversold.50 million vaccine doses headed for Africa.
PFE LongWe are seeing a healthy crossover of both the RSX and the Klinger, along with the change in momentum on the VI, could see a nice short term target of 40
